Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCreg Infusion and Immunosuppression Withdrawal in LDLT Recipients
NCT04208919Phase 2Completed
- Start
- Dec 2019
- Primary completion
- Dec 2025
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Regulatory Donor-Derived Dendritic Cell. Started Dec 2019; status: completed.
02
Drugs
Regulatory Donor-Derived Dendritic Cell
Beyond the preview
Go deeper on NCT04208919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04208919.